HALO

HALOZYME THERAPEUTICS INC

Healthcare | Mid Cap

$1.66

EPS Forecast

$349.8

Revenue Forecast

Announcing earnings for the quarter ending 2025-09-30 soon
REPLReplimune Group IncCRBUCaribou Biosciences IncRVMDRevolution Medicines IncDNLIDenali Therapeutics IncIOVAIovance Biotherapeutics Inc